GlassScriptPhysician profile
Whitney Latin
NPI 1265882690
$5,666.71
in general payments reported to CMS, 2019-2025
33 companies · $1,465 in 2025
The $1,465 reported for 2025 was more than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $882 · 2020: $207 · 2021: $847 · 2022: $1,042 · 2023: $614 · 2024: $610 · 2025: $1,465.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,361 · Education: $329.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,360.61 |
| Education | $329.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $687.11 | 2019-2025 | Tremfya |
| Genzyme Corporation | $617.81 | 2020-2025 | |
| Abbvie INC. | $553.62 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $436.77 | 2019-2023 | |
| Sun Pharmaceutical Industries INC. | $359.26 | 2019-2025 | Ilumya |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $282.60 | 2019-2022 | |
| Incyte Corporation | $278.54 | 2021-2025 | Opzelura |
| Regeneron Healthcare Solutions, INC. | $266.80 | 2021-2025 | Dupixent, Libtayo |
| Lilly USA, LLC | $205.22 | 2020-2025 | Taltz, Ebglyss, Olumiant |
| Galderma Laboratories, L.P. | $186.17 | 2020-2025 | Nemluvio, Aklief, Epsolay |
| Amgen INC. | $183.41 | 2021-2022 | |
| Organon LLC | $174.69 | 2025 | Vtama |
| Leo Pharma INC. | $167.68 | 2020-2025 | Adbry, Anzupgo |
| E.R. Squibb & Sons, L.L.C. | $143.37 | 2022-2025 | Sotyktu |
| Ucb, INC. | $139.03 | 2021-2025 | Bimzelx, Cimzia |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Journey Medical Corporation | $124.52 | 2022-2024 | |
| Allergan, INC. | $97.33 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $93.25 | 2024-2025 | Spevigo |
| Biofrontera INC. | $84.41 | 2021-2023 | Xepi, Bf-Rhodoled, Ameluz |
| Almirall LLC | $76.65 | 2020-2024 | Seysara |
| Arcutis Biotherapeutics, INC. | $74.77 | 2023-2025 | Zoryve |
| Mayne Pharma Commercial LLC | $70.32 | 2020-2023 | |
| Endo Pharmaceuticals INC. | $67.57 | 2019 | |
| Pfizer INC. | $65.60 | 2021-2023 | |
| Epi Health, LLC | $44.19 | 2021-2022 | |
| Vyne Pharmaceuticals INC. | $43.02 | 2021 | |
| Dermavant Sciences, INC. | $30.69 | 2023 | Vtama |
| Convatec INC. | $25.99 | 2025 | |
| Mallinckrodt Hospital Products INC. | $21.50 | 2025 | Acthar |
| Fidia Pharma USA INC. | $18.01 | 2024 | |
| Botanix Sb INC | $17.00 | 2025 | Sofdra |
| Dermira, INC. | $15.00 | 2021 | |
| Genentech USA, INC. | $14.81 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Whitney Latin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.